Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

70.54EUR
4:35pm GMT
Change (% chg)

€3.06 (+4.53%)
Prev Close
€67.48
Open
€70.06
Day's High
€72.22
Day's Low
€69.66
Volume
1,974,201
Avg. Vol
1,102,178
52-wk High
€91.74
52-wk Low
€55.44

Select another date:
Photo

Fresenius flags faster earnings growth from 2020 after investment

BERLIN Fresenius expects earnings to grow faster than sales from 2020 after investments to improve its German hospitals and scale up its home dialysis business eat up profit this year, the German healthcare group said on Wednesday.

FMC expects NxStage deal to close in next couple of days

BERLIN Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

UPDATE 2-Fresenius flags faster earnings growth from 2020 after investment

* Announces 1 bln euros share buyback at Fresenius Medical Care

FMC expects NxStage deal to close in next couple of days

BERLIN, Feb 20 Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

RPT-Fresenius Medical Care plans 1 bln eur share buyback

BERLIN, Feb 20 Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

Fresenius Medical Care plans 1 bln eur share buyback

BERLIN, Feb 20 Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

Fresenius expects earnings to stagnate in 2019 as investments weigh

BERLIN, Feb 20 German healthcare group Fresenius said sales growth would slow and profit stagnate this year as investments to fix the performance at its German hospitals business and build up home dialysis take a toll.

U.S. approves Fresenius purchase of NxStage

WASHINGTON The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

UPDATE 2-U.S. approves Fresenius purchase of NxStage

WASHINGTON, Feb 19 The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

US approves Fresenius purchase of NxStage with conditions

WASHINGTON, Feb 19 The U.S. Federal Trade Commission has given Fresenius Medical Care AG and NxStage Medical Inc antitrust approval for their merger with conditions, the agency said on Tuesday. (Reporting by Diane Bartz Editing by James Dalgleish)

Select another date: